From Cystic Fibrosis Foundation <[email protected]>
Subject Together: a Community Update
Date March 7, 2024 9:22 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Our latest research funding announcement


([link removed])


# March 7, 2024



CF Foundation Invests More Than $6.6 Million in Additional Funding in Sionna Therapeutics


We have invested more than $6.6 million in additional funding in Sionna Therapeutics ([link removed])
to continue research into the development of potential new modulator therapies for people with cystic fibrosis with an F508del mutation. If successful, these therapies would provide other options to people with CF, especially those who cannot tolerate current modulator therapies because of side effects.

More about our investment » ([link removed])


([link removed])




Bruce Marshall, Chief Medical Officer, to Retire From the CF Foundation


Bruce Marshall, MD, will retire from his role at the CF Foundation as of July 1, 2024 ([link removed]). Throughout his tenure, Dr. Marshall has overseen activities related to clinical care for the Foundation, including the care center network, quality improvement initiatives, clinical practice guidelines, and more.

Read the announcement » ([link removed])


([link removed])




Share Your Insights in Spanish With Community Voice

Community Voice now offers
opportunities for Spanish-speaking members of the CF community to actively impact research, care, and programs ([link removed]). As a member of Community Voice, you can provide crucial input from the Spanish-speaking CF community on the topics, initiatives, and programs that matter most to you. Your insights are unique and valuable, and sharing them will improve the future for the entire CF community. Sign up today, or share this with a friend, to receive opportunities in English or in Spanish.

Join Community Voice » ([link removed])


([link removed])




Raise Your Voice for Everyone with CF

The needs of the cystic fibrosis community are unique, and there's no one better to tell your story than you! Add your voice to ensure your elected officials prioritize the needs of people with CF and
sign up for advocacy alerts today ([link removed]).

Get advocacy alerts » ([link removed])


([link removed])




Updated COVID-19 Guidance From the CDC

The CDC eliminated independent COVD-19 guidance, combining it with
guidance for respiratory viruses ([link removed]). The update includes staying away from others until fever is gone and overall symptoms improve for at least 24 hours. Other precautions after returning to normal activities include:

* Wearing a well-fitting mask
* Enhancing hygiene practices
* Maintaining physical distance from others
* Testing for respiratory viruses

People at risk for severe illness, including those who are older than 65 or are immunosuppressed, should continue to take extra precautions, including getting vaccinated, wearing a mask, and taking appropriate antiviral medications.

Learn more » ([link removed])


([link removed])


Support ([link removed])•
Get Involved ([link removed])

CF Community Blog ([link removed])


SIGN UP FOR RESEARCH UPDATES ([link removed])


([link removed])


www.cff.org ([link removed])

www.cff.org en español ([link removed])


4550 Montgomery Avenue, Suite 1100N | Bethesda, MD 20814 US



DONATE ([link removed])


([link removed])
([link removed])
% link:[link removed] name="[link removed]" content="" %]
% link:[link removed] name="[link removed]" content="" %]
% link:[link removed] name="[link removed]" content="" %]


[Opt out]([link removed]) of this mailing list

Opt out ([link removed])
out of all CF Foundation emails

This email was sent to [email protected]

Got this as a forward? [Sign up]([link removed]) to receive our future emails.
Screenshot of the email generated on import

Message Analysis